These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11964888)

  • 21. [Clinical management of community-acquired pneumonia].
    Pachón J; Alcántara Jde D; Cordero E; Lama C; Rivero A
    Enferm Infecc Microbiol Clin; 2003; 21(7):350-7. PubMed ID: 14525691
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.
    Venditti M; Falcone M; Corrao S; Licata G; Serra P;
    Ann Intern Med; 2009 Jan; 150(1):19-26. PubMed ID: 19124816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of severe community-acquired pneumonia among younger patients: an analysis of 18 years at a community hospital.
    Ishida T; Tachibana H; Ito A; Tanaka M; Tokioka F; Furuta K; Nishiyama A; Ikeda S; Niwa T; Yoshioka H; Arita M; Hashimoto T
    J Infect Chemother; 2014 Aug; 20(8):471-6. PubMed ID: 24951291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance.
    Peyrani P; Mandell L; Torres A; Tillotson GS
    Expert Rev Respir Med; 2019 Feb; 13(2):139-152. PubMed ID: 30596308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
    Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
    J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use and limitations of clinical and radiologic diagnosis of pneumonia.
    Mabie M; Wunderink RG
    Semin Respir Infect; 2003 Jun; 18(2):72-9. PubMed ID: 12840787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacoeconomic efficiency of sparfloxacin use in empiric therapy of community-acquired pneumonia].
    Lazareva NB
    Antibiot Khimioter; 2007; 52(7-8):53-7. PubMed ID: 18986025
    [No Abstract]   [Full Text] [Related]  

  • 28. [Community-acquired pneumonia in the elderly requiring hospitalization. Clinical features and prognosis].
    Díaz Fuenzalida A; Vera C; Santamarina J; Izarduy L; Bagnasco R; Grinspon S; Khoury M; Rodríguez CH; Luna CM
    Medicina (B Aires); 1999; 59(6):731-8. PubMed ID: 10752217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-acquired pneumonia.
    Cassiere HA; Niederman MS
    Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina.
    Luna CM; Famiglietti A; Absi R; Videla AJ; Nogueira FJ; Fuenzalida AD; Gené RJ
    Chest; 2000 Nov; 118(5):1344-54. PubMed ID: 11083685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of survey of adult community-acquired pneumonia utilizing flow chart of diagnostic guideline for management of respiratory infections].
    Watanabe A; Matsushima T; Kohno S; Abe S; Aoki N; Kubo K; Sugiyama Y; Kikuchi N; Kudou S; Ishigatsubo Y; Shimokata K; Hirata K; Tohda Y; Narita N; Ueda N; Niki Y; Nasu M; Saitou A
    Nihon Kokyuki Gakkai Zasshi; 2003 Nov; 41(11):781-96. PubMed ID: 14661550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.
    Ruiz M; Ewig S; Torres A; Arancibia F; Marco F; Mensa J; Sanchez M; Martinez JA
    Am J Respir Crit Care Med; 1999 Sep; 160(3):923-9. PubMed ID: 10471620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory community-acquired pneumonia: the predominance of atypical pathogens.
    Cunha BA
    Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):579-83. PubMed ID: 14649230
    [No Abstract]   [Full Text] [Related]  

  • 35. [Community-acquired pneumonia].
    Blanquer J; Sanz F
    Arch Bronconeumol; 2010 Oct; 46 Suppl 7():26-30. PubMed ID: 21316547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aetiology and outcome of severe community-acquired pneumonia in Singapore.
    Tan YK; Khoo KL; Chin SP; Ong YY
    Eur Respir J; 1998 Jul; 12(1):113-5. PubMed ID: 9701424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neumonía acquired in the community. Practical guide elaborated by a committee intersocieties].
    Luna CM; Calmaggi A; Caberloto O; Gentile J; Valentini R; Ciruzzi J; Clara L; Rizzo O; Lasdica S; Blumenfeld M; Benchetrit G; Famiglietti A; Apezteguia C; Monteverde A;
    Medicina (B Aires); 2003; 63(4):319-43. PubMed ID: 14518147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence based medicine: review of BTS guidelines for the management of community acquired pneumonia in adults.
    Mckean MC
    J Infect; 2002 Nov; 45(4):213-8. PubMed ID: 12423607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-acquired pneumonia.
    Stein RT; Marostica PJ
    Paediatr Respir Rev; 2006; 7 Suppl 1():S136-7. PubMed ID: 16798540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Re-evaluation of the etiology of community-acquired pneumonia: the impact of the age of comorbidity and of the severity of the pneumonia and of other additional factors].
    Torres A
    Arch Bronconeumol; 1999 May; 35 Suppl 3():62-4. PubMed ID: 10410227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.